Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

METHOD FOR DETECTING HTLV-III NEUTRALIZING ANTIBODIES IN SERA

  • Read more about METHOD FOR DETECTING HTLV-III NEUTRALIZING ANTIBODIES IN SERA
US Patent 4,755,457
Filed on 1987-04-20

ACID STABLE PYRIMIDINE DIDEOXYNUCLEOSIDES ACTIVE AGAINST THE CYTOPATHIC EFFECTS OF HUMAN IMMUNODEFICIENCY VIRUS

  • Read more about ACID STABLE PYRIMIDINE DIDEOXYNUCLEOSIDES ACTIVE AGAINST THE CYTOPATHIC EFFECTS OF HUMAN IMMUNODEFICIENCY VIRUS
US Application 07/039,402
Filed on 1987-04-17

Anti-Retroviral Agents and Delivery System for the Same

  • Read more about Anti-Retroviral Agents and Delivery System for the Same
US Application 07/037,178
Filed on 1987-04-10

Molecular Clones of the Genome of HTLV-III

  • Read more about Molecular Clones of the Genome of HTLV-III
US Application 07/033,891
Filed on 1987-04-03

PACKAGING DEFECTIVE DELETION MUTANT OF HTLV-III

  • Read more about PACKAGING DEFECTIVE DELETION MUTANT OF HTLV-III
US Application 06/912,324
Filed on 1986-09-29

Detection of Human T-Cell Leukemia Virus Type III

  • Read more about Detection of Human T-Cell Leukemia Virus Type III
US Application 07/031,213
Filed on 1987-03-27

PHOSPHOROTHIOATE ANALOGUES OF OLIGODEOXYRIBONUCLEOTIDES AS INHIBITORS FOR REPLICATION AND CYTOPATHIC EFFECTS OF HTLV-3

  • Read more about PHOSPHOROTHIOATE ANALOGUES OF OLIGODEOXYRIBONUCLEOTIDES AS INHIBITORS FOR REPLICATION AND CYTOPATHIC EFFECTS OF HTLV-3
US Application 07/030,073
Filed on 1987-03-25

Substituted N-Methyl Derivatives of Mitindomide

  • Read more about Substituted N-Methyl Derivatives of Mitindomide
US Patent 4,803,202
Filed on 1987-03-12

ANTINEOPLASTIC, SYSTEM -L SPECIFIC AMINO ACID NITROGEN MUSTARDS

  • Read more about ANTINEOPLASTIC, SYSTEM -L SPECIFIC AMINO ACID NITROGEN MUSTARDS
US Patent 4,772,632
Filed on 1987-02-24

SYNTHETIC PEPTIDES WHICH INDUCE CELLULAR IMMUNITY TO THE AIDS VIRUS AND AIDS VIRAL PROTEINS

  • Read more about SYNTHETIC PEPTIDES WHICH INDUCE CELLULAR IMMUNITY TO THE AIDS VIRUS AND AIDS VIRAL PROTEINS
US Application 07/014,430
Filed on 1987-02-12

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1661
  • Page 1662
  • Page 1663
  • Page 1664
  • Page 1665
  • Page 1666
  • Page 1667
  • Page 1668
  • Page 1669
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health